Epsilon Healthcare Limited (ASX:EPN)
Australia · Delayed Price · Currency is AUD 0.0250
0.00 (0.00%)
Mar 4, 2026, 3:54 PM AEST
Epsilon Healthcare Revenue
In the year 2025, Epsilon Healthcare had annual revenue of 9.39M AUD with 67.74% growth. Epsilon Healthcare had revenue of 3.40M in the half year ending June 30, 2025, with 2.75% growth.
Revenue
9.39M
Revenue Growth
+67.74%
P/S Ratio
1.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.39M | 3.79M | 67.74% |
| Dec 31, 2024 | 5.60M | -1.05M | -15.81% |
| Dec 31, 2023 | 6.65M | 2.00M | 42.99% |
| Dec 31, 2022 | 4.65M | -846.35K | -15.39% |
| Dec 31, 2021 | 5.50M | -1.46M | -20.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 129.24M |
| Little Green Pharma | 38.49M |
| ECS Botanics Holdings | 19.36M |
| IDT Australia | 19.00M |
| Elixinol Wellness | 16.49M |
| Peak Processing | 14.59M |
| Cann Group | 13.25M |
| Percheron Therapeutics | 1.74M |